William Dull Email & Phone Number

Atlanta, Georgia, US

• BiotechExec empowers life science companies to bring groundbreaking, life-saving products to market. We employ a fractional CXO model, forge strategic partnerships, facilitate fundraising, provide operational support.
• Member of the Executive team leading operations, business development, marketing, strategic planning and channel & partner strategies.
• Doubled revenue growth in 2023, grew 3X number of clients and increased margins to 60% by revamping a go-to-market strategy, marketing focus and process improvement activities.
• Collaborated with state BIO associations, venture capital/private equity firms, and university technology transfer offices to pinpoint potential clients for incubation and scaling.
• Developed the PrecisionMatch process designed to identify and hire the precise candidate for clients.
• Provide C-suite advisory & consultative services and strategic business solutions to clients including development of business planning & commercial assessment, growth strategies, fund raising activities, FP&A.

New York, NY, US

InnoMed Infertility Division is a female founded women's health company bringing innovation to the field of infertility. Our goal is to create a new standard of care by researching, developing and commercializing novel medical devices and reproductive methodologies for the infertility space, where there has been a lack of innovation for decades. We are.

Boston, Massachusetts, US

• Founding executive team member of a new healthcare company (FemTech) dedicated to diagnosing, treating, and improving women's pelvic floor disorders.
• Oversaw P&L, commercial, manufacturing, finance, and business operations.
• Developed transformational products for value-based care using innovative sensor technologies and a digital health app, setting a new standard in women’s health.
• Created and launched Go-To-Market Strategy for Gen 1 product, including HCP and consumer campaigns executed by sales, marketing, operations, access, analytics, and patient hub teams.
• Secured Series A & B funding, negotiated a Worldwide IP exclusive license agreement, managed tech-transfer, product and app integration, and led cross-functional R&D for next-gen products.
• Built organizational blueprint covering Sales & Marketing, HR, Medical Affairs, Facilities, Manufacturing, Supply Chain, IP, Finance, Market Access, Patient Engagement, Quality, IT, Reimbursement, Compliance.

• Developed and headed the global rare disease go-to-market commercialization strategy and execution for the US, EMEA, and International regions to successfully launch a portfolio of therapeutics (lomitapide and.
• Led high-performing global teams consisting of market research, HCP/Patient marketing, patient advocacy, psales operations and training, analytics, and promotional review.
• Formulated global forecasting, access and pricing strategies, and as a key member of the Lifecycle Management Team, established regulatory priorities and explored new formulations and label expansions.
• Notable achievements while in the position included:o Orchestrated global brand strategies which accelerated launches in multiple counties, leading to $250M in global sales in 2015.o Successfully integrated and.

• Built a new department from the ground-up with a focus on all patient-related activities that included teams of Nurses (PEM), Registered Dietitians, and Patient Marketing for our rare disease platform.
• Led marketing groups in the design and execution of all patient models, adherence tactics, resources, and interventions to enhance the patient experience and implement a focus on a commitment to treating their specific.
• Worked in collaboration with VP Patient Services on Specialty Pharmacy (SP) strategies and tactics to optimize patient care through an in-house Case Management Group.
• Notable achievements while in the position included:o Increased PEM patient on-boarding to 80% and RD consults to 90%, resulting in higher patient conversion and adherence rates. o Decreased patient-elected drops by.

• Recruited, hired and managed a group of high-performing sales teams to prepare the company to launch novel therapeutics in the rare/orphan space and to drive the achievement of defined US sales performance targets.
• Partnered with US Marketing, Medical Affairs, and Commercial Operations to develop and execute the launch plan, KOL management, sales meetings, performance analytics, KPIs, and training materials.
• Worked in collaboration with Managed Care teams to ensure patient and HCP access/coverage to the product.
• Notable achievements while in the position included:o Recognized as a “President Cup” winner in 2013.o Ignited sales team to achieve a 2X revenue launch forecast of year 1 sales of $40M.o Delivered 90%+ in market share.

• Brought on board specifically to establish and operationalize the Sales department including Sales Operations, Analytics and Business Intelligence, Human Resources, and Sales Training of a newly formed neurology company.
• Partnered and oversaw the outsourcing organization to develop and execute the launch readiness sales plan.
• Teamed with head of sales, assembled and hired an organization comprised of 9 Regional Business Sales Directors and 110 Field Specialty Representatives.
• Added valued input while supporting the identification of SP distribution strategies and the HUB support systems, payer/pricing research and value proposition.
• Notable achievements while in the position included:o Developed the overall commercial strategy and launch of the Alliance for HOH, a coalition of KOL physicians and patient advocacy groups that increased disease.

Oklahoma City, OK, US

• Member of the Executive Management Team, led P&L, finance, contracting, sales and marketing, project and program management, business and corporate development activities, and all client-related services in the Protein.
• Worked in collaboration with contracted companies to optimize product development to maximize market potential.
• Evaluated protein expression platforms and scientific technologies aimed at expanding the menu of services.
• Focused on capital efficiencies, cash flow, balance sheet, OPEX and resource allocation to ensure corporate growth.
• Notable achievements while in the position included:o Maintained full responsibility for profit & loss, devised and implemented the business development strategy that grew revenue from $3M to $7M in 2010 and.